Pharma & Bio
Almost one in two pharmaceutical European and US companies surveyed (48%) say their competitiveness is impaired by their inability extract or use insights from the data they already possess.
Selecting the right vacuum technology for chemical and pharmaceutical processing applications is often difficult, cautions Uli Merkle.
The scale of pharmaceutical counterfeiting can be staggering to behold – whether in terms of the number of cases, the financial incentives or the economic loss to the legitimate industry.
Comment & Features
Recent events have underlined the need for pharmaceutical innovation and are encouraging more inventive and holistic approaches, reports Brian Attwood.